MONDAY, Dec. 13, 2021 (HealthDay News) — Parents of children with moderate-to-severe asthma may have a much-needed treatment option: A new trial finds that an injected monoclonal antibody drug called dupilumab significantly reduces a child’s odds of serious asthma attacks and improves lung function. “We were not surprised, because dupilumabContinue Reading